Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|August 27, 2010
Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesionsAlessandro Fasciani, Paolo Quilici, Ennio Biscaldi, et al.
Pharmacogenomics|April 11, 2013
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degenerationStefano Lazzeri, Michele Figus, Paola Orlandi, et al.
Advances in Therapy|December 20, 2018
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE ProjectMarina E Cazzaniga, Elisabetta Munzone, Guido Bocci, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2006
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluationGiacomo Allegrini, Antonello Di Paolo, Elisa Cerri, et al.
Anticancer Research|January 1, 2015
Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapyFrancesco Pasqualetti, Guido Bocci, Valentina Mey, et al.
Scientific Reports|July 11, 2019
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional InvestigationLuca Quattrini, Vito Coviello, Stefania Sartini, et al.
Archiv Der Pharmazie|July 29, 2022
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effectsMarco Robello, Silvia Salerno, Elisabetta Barresi, et al.
European Journal of Pharmacology|September 15, 2004
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabineGuido Bocci, Romano Danesi, Gabriele Marangoni, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2020
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphomaMaria Christina Cox, Marta Banchi, Sabrina Pelliccia, et al.
Future Oncology (London, England)|November 20, 2015
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future developmentMarina E Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
Pageof 16